Noting that Novo Nordisk, the maker of semaglutide, has a net worth exceeding US$550 billion, Collins said: We should be working with the Medicines Patent Pool so that people in South Africa and other countries with obesity epidemics also have access to this product. Lake J et al (Price J presenting)
On 5 February 2026, well be hosting a session titled: Global GLP-1 disruption
These strategies resulted in a gain of 400,018 years of life lived and 176,446 QALYS for SGLT2is, and a gain of 460,028 years of life lived and 200,932 QALYs for GLP-1 RAs
---According to some authorities: A risk to a breastfed child cannot be excluded
Ideal temperature is 15-30C
Unjust enrichment claims allow courts to order disgorgement of profits earned through deception